Delivering high quality metabolomics data
Human Metabolome Technologies (humanmetabolome.com) scores 64 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Technology brands, Other brands, in the 10th percentile of 8510 Healthcare brands.
Human Metabolome Technologies (HMT), founded in 2003 and headquartered in Yamagata Prefecture, Japan, provides metabolomics analysis services. The company operates advanced metabolomics platforms to generate precise metabolic data used by researchers, biotech and pharmaceutical companies, and healthcare organizations. Its stated mission is to deliver high-quality metabolomics data to help address scientific and health challenges, positioning itself as a global leader in the metabolomics analysis field.
| Brand Name | Human Metabolome Technologies |
|---|---|
| Domain | humanmetabolome.com |
| Industry | Healthcare, Technology |
| Founded | 2003 |
| Headquarters | Yamagata Prefecture |
| Main Competitors | Metabolon (83/100), Biocrates Life Sciences (81/100), Creative Proteomics, Metware Biotechnology, Agilent Technologies (79/100) |
Moz Domain Authority 39/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,079,864 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To deliver the highest quality metabolomics data to help solve today's scientific and health challenges." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram; no detected presence on LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Human Metabolome Technologies?", Claude could identify the brand as of September 2026. Human Metabolome Technologies is a Japanese biotech company spun out of Keio University that specializes in metabolome analysis, using capillary electrophoresis mass spectrometry (CE-MS) technology pioneered by researcher Tomoyoshi Soga to profile metabolites for pharmaceutical, Best known for Metabolome analysis services using proprietary CE-MS technology for drug discovery and biomarker research.
When asked "Best brands similar to Human Metabolome Technologies?", Claude would recommend Human Metabolome Technologies as of September 2026. It's a recognized name in metabolomics services, especially in Japan and Asia, so it would come up for someone looking for specialized metabolite profiling providers.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Human Metabolome Technologies's main competitors in Healthcare: Metabolon (83/100), Biocrates Life Sciences (81/100), Agilent Technologies (79/100).
Sources: Brand Analyzer scan
Human Metabolome Technologies has limited AI-search visibility, scoring 28/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 22, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Human Metabolome Technologies was founded in 2003. Human Metabolome Technologies operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Human Metabolome Technologies is headquartered in Yamagata Prefecture. Human Metabolome Technologies operates in the Healthcare category.
Sources: Wikidata
Human Metabolome Technologies scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Human Metabolome Technologies can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Human Metabolome Technologies (HMT) is a company founded in 2003 and headquartered in Yamagata Prefecture, Japan, that specializes in metabolomics analysis. It provides data and analytical services related to the study of metabolites, aiming to support scientific research and health-related applications.
Human Metabolome Technologies' services are used by researchers, biotech and pharmaceutical companies, and healthcare organizations seeking advanced metabolomics data for scientific discovery and product development.
Human Metabolome Technologies scores 28/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Human Metabolome Technologies has a weak AI-visibility profile at 28/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is trust (22/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #2,079,864 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 39/100 and thin schema.org structured data. In a live check, Claude could already identify Human Metabolome Technologies from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Human Metabolome Technologies: HOSH (64/100), Hôpital Montfort (64/100), IADSA (64/100), iScribe Health (64/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.